Boston Partners Buys New Shares in Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Boston Partners purchased a new stake in Cross Country Healthcare, Inc. (NASDAQ:CCRNFree Report) during the 1st quarter, Holdings Channel reports. The firm purchased 134,111 shares of the business services provider’s stock, valued at approximately $2,511,000.

Other large investors also recently modified their holdings of the company. GAMMA Investing LLC acquired a new position in shares of Cross Country Healthcare during the 4th quarter worth approximately $28,000. Gladius Capital Management LP increased its holdings in Cross Country Healthcare by 37.1% during the fourth quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider’s stock worth $43,000 after buying an additional 515 shares during the last quarter. Denali Advisors LLC raised its position in Cross Country Healthcare by 3,885.5% during the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock worth $103,000 after acquiring an additional 5,362 shares in the last quarter. EMC Capital Management acquired a new stake in Cross Country Healthcare in the 1st quarter valued at about $155,000. Finally, Bayesian Capital Management LP bought a new position in Cross Country Healthcare during the first quarter worth about $195,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on CCRN. Barrington Research dropped their price objective on Cross Country Healthcare from $24.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday, May 6th. Benchmark dropped their price target on Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Finally, Truist Financial upped their price objective on shares of Cross Country Healthcare from $16.00 to $17.00 and gave the company a “hold” rating in a report on Thursday. Six investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Cross Country Healthcare currently has a consensus rating of “Hold” and a consensus price target of $21.00.

View Our Latest Stock Report on CCRN

Insider Buying and Selling at Cross Country Healthcare

In related news, insider Marc S. Krug sold 13,657 shares of Cross Country Healthcare stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $14.82, for a total value of $202,396.74. Following the transaction, the insider now directly owns 36,020 shares of the company’s stock, valued at $533,816.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Marc S. Krug sold 13,657 shares of the company’s stock in a transaction on Thursday, May 30th. The stock was sold at an average price of $14.82, for a total transaction of $202,396.74. Following the completion of the sale, the insider now directly owns 36,020 shares in the company, valued at approximately $533,816.40. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Phillip Lyn Noe sold 9,646 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $14.19, for a total value of $136,876.74. Following the completion of the sale, the insider now directly owns 10,162 shares in the company, valued at $144,198.78. The disclosure for this sale can be found here. Insiders own 4.90% of the company’s stock.

Cross Country Healthcare Stock Down 2.5 %

Shares of Cross Country Healthcare stock traded down $0.44 during trading on Friday, reaching $17.11. The company’s stock had a trading volume of 593,035 shares, compared to its average volume of 408,566. The business’s 50-day moving average price is $14.76 and its 200-day moving average price is $17.01. Cross Country Healthcare, Inc. has a 52 week low of $12.87 and a 52 week high of $26.17. The firm has a market cap of $594.91 million, a PE ratio of 13.16, a P/E/G ratio of 2.57 and a beta of 0.63.

Cross Country Healthcare (NASDAQ:CCRNGet Free Report) last released its earnings results on Wednesday, July 31st. The business services provider reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.04). The company had revenue of $339.77 million for the quarter, compared to analyst estimates of $334.75 million. Cross Country Healthcare had a return on equity of 7.29% and a net margin of 0.54%. The business’s revenue for the quarter was down 37.2% compared to the same quarter last year. During the same period last year, the company posted $0.69 earnings per share. Equities analysts predict that Cross Country Healthcare, Inc. will post 0.68 earnings per share for the current year.

About Cross Country Healthcare

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Read More

Want to see what other hedge funds are holding CCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cross Country Healthcare, Inc. (NASDAQ:CCRNFree Report).

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.